Kidney Fibrosis Treatment Market Size, Share, Trends, Growth and Forecast 2032
Kidney Fibrosis Treatment Market - By Therapeutics (Angiotensin II Receptor Blockers, Angiotensin Converting Enzyme Inhibitors, Renin Inhibitors, Pirfenidone, and Vasopeptidase Inhibitors), By Location Of Testing (Commercial/Private Hospitals, Hospital Testing, Clinics, Public Health Hospitals, and Home Treatment), And By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 4.78 Billion | USD 7.65 Billion | 4.8% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Kidney Fibrosis Treatment Market, 2015–2025 (USD Billion)
- 2.2. Kidney Fibrosis Treatment Market: Snapshot
- Chapter 3. Global Kidney Fibrosis Treatment Market– Industry Analysis
- 3.1. Kidney Fibrosis Treatment Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Escalating occurrence of chronic disorders due to unhealthy food habits has resulted in kidney fibrosis cases, thereby culminating into huge market demand in the upcoming years.
- 3.2.2. Surge in the aging population along with massive awareness pertaining to renal fibrosis therapy will prompt the kidney fibrosis market expansion over the forthcoming years.
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By Therapeutics
- 3.4.2. Market attractiveness analysis By Material
- Chapter 4. Global Kidney Fibrosis Treatment Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Kidney Fibrosis Treatment Market: company market share, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Product launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Kidney Fibrosis Treatment Market– Therapeutics Analysis
- 5.1. Global Kidney Fibrosis Treatment Market overview: By Therapeutics
- 5.1.1. Global Kidney Fibrosis Treatment Market share, By Therapeutics , 2019 and 2025
- 5.2. Angiotensin II Receptor Blockers
- 5.2.1. Global Kidney Fibrosis Treatment Market By Angiotensin II Receptor Blockers , 2015–2025 (USD Billion)
- 5.3. Angiotensin Converting Enzyme Inhibitors
- 5.3.1. Global Kidney Fibrosis Treatment Market By Angiotensin Converting Enzyme Inhibitors, 2015–2025 (USD Billion)
- 5.4. Renin Inhibitors
- 5.4.1. Global Kidney Fibrosis Treatment Market By Renin Inhibitors , 2015–2025 (USD Billion)
- 5.5. Pirfenidone
- 5.5.1. Global Kidney Fibrosis Treatment MarketBy Pirfenidone, 2015–2025 (USD Billion)
- 5.6. Vasopeptidase Inhibitors
- 5.6.1. Global Kidney Fibrosis Treatment MarketBy Vasopeptidase Inhibitors, 2015–2025 (USD Billion)
- 5.1. Global Kidney Fibrosis Treatment Market overview: By Therapeutics
- Chapter 6. Global Kidney Fibrosis Treatment Market– Location of Testing Analysis
- 6.1. Global Kidney Fibrosis Treatment Market overview: By Location of Testing
- 6.1.1. Global Kidney Fibrosis Treatment Market share, By Location of Testing , 2019 and 2025
- 6.2. Commercial/Private Hospitals
- 6.2.1. Global Kidney Fibrosis Treatment Market By Commercial/Private Hospitals, 2015–2025 (USD Billion)
- 6.3. Hospital Testing
- 6.3.1. Global Kidney Fibrosis Treatment Market By Hospital Testing, 2015–2025 (USD Billion)
- 6.4. Clinics
- 6.4.1.1. Global Kidney Fibrosis Treatment Market By Clinics, 2015–2025 (USD Billion)
- 6.5. Public Health Hospitals
- 6.5.1.1. Global Kidney Fibrosis Treatment Market By Public Health Hospitals, 2015–2025 (USD Billion)
- 6.6. Home Treatment
- 6.6.1.1. Global Kidney Fibrosis Treatment Market By Home Treatment, 2015–2025 (USD Billion)
- 6.1. Global Kidney Fibrosis Treatment Market overview: By Location of Testing
- Chapter 7. Company Profiles
- 7.1. F. Hoffman-La Roche Ltd.
- 7.1.1. Overview
- 7.1.2. Financials
- 7.1.3. Service Portfolio
- 7.1.4. Business Strategy
- 7.1.5. Recent Developments
- 7.2. Merck & Co.
- 7.2.1. Overview
- 7.2.2. Financials
- 7.2.3. Service Portfolio
- 7.2.4. Business Strategy
- 7.2.5. Recent Developments
- 7.3. Galectin Therapeutics
- 7.3.1. Overview
- 7.3.2. Financials
- 7.3.3. Service Portfolio
- 7.3.4. Business Strategy
- 7.3.5. Recent Developments
- 7.4. Pfizer Inc.
- 7.4.1. Overview
- 7.4.2. Financials
- 7.4.3. Service Portfolio
- 7.4.4. Business Strategy
- 7.4.5. Recent Developments
- 7.5. InterMune Inc.
- 7.5.1. Overview
- 7.5.2. Financials
- 7.5.3. Service Portfolio
- 7.5.4. Business Strategy
- 7.5.5. Recent Development
- 7.6. La Julla Pharmaceutical Company
- 7.6.1. Overview
- 7.6.2. Financials
- 7.6.3. Service Portfolio
- 7.6.4. Business Strategy
- 7.6.5. Recent Development
- 7.7. Genzyme Corporation
- 7.7.1. Overview
- 7.7.2. Financials
- 7.7.3. Service Portfolio
- 7.7.4. Business Strategy
- 7.7.5. Recent Development
- 7.8. ProMetic Life-Sciences Inc.
- 7.8.1. Overview
- 7.8.2. Financials
- 7.8.3. Service Portfolio
- 7.8.4. Business Strategy
- 7.8.5. Recent Development
- 7.9. BioLine Rx Ltd
- 7.9.1. Overview
- 7.9.2. Financials
- 7.9.3. Service Portfolio
- 7.9.4. Business Strategy
- 7.9.5. Recent Development
- 7.1. F. Hoffman-La Roche Ltd.
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Kidney Fibrosis Treatment Market, 2015–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Kidney Fibrosis Treatment Market attractiveness, By Therapeutics
6. Global Kidney Fibrosis Treatment Market attractiveness, By Location of Testing
7. Global Kidney Fibrosis Treatment Market Share by Therapeutics ,2019 and 2025 (USD Billion)
8. Global Kidney Fibrosis Treatment Market by Angiotensin II Receptor Blockers ,2015–2025 (USD Billion)
9. Global Kidney Fibrosis Treatment Market by Angiotensin Converting Enzyme Inhibitors ,2015–2025 (USD Billion)
10. Global Kidney Fibrosis Treatment Market by Renin Inhibitors ,2015–2025 (USD Billion)
11. Global Kidney Fibrosis Treatment Market by Pirfenidone ,2015–2025 (USD Billion)
12. Global Kidney Fibrosis Treatment Market by Vasopeptidase Inhibitors ,2015–2025 (USD Billion)
13. Global Kidney Fibrosis Treatment Market Share by Location of Testing,2019 and 2025 (USD Billion)
14. Global Kidney Fibrosis Treatment Market by Commercial/Private Hospitals,2015–2025 (USD Billion)
15. Global Kidney Fibrosis Treatment Market by Hospital Testing,2015–2025 (USD Billion)
16. Global Kidney Fibrosis Treatment Market by Clinics,2015–2025 (USD Billion)
17. Global Kidney Fibrosis Treatment Market by Public Health Hospitals,2015–2025 (USD Billion)
18. Global Kidney Fibrosis Treatment Market by Home Treatment,2015–2025 (USD Billion)
19. Global Kidney Fibrosis Treatment Market share, by Region, 2019 and 2025
20. North America Kidney Fibrosis Treatment Market, 2015–2025 (USD Billion)
21. Europe Kidney Fibrosis Treatment Market, 2015–2025 (USD Billion)
22. Asia Pacific Kidney Fibrosis Treatment Market, 2015–2025 (USD Billion)
23. Latin America Kidney Fibrosis Treatment Market, 2015–2025 (USD Billion)
24. The Middle East and Africa Kidney Fibrosis Treatment Market, 2015–2025 (USD Billion)
Table Of Tables
List of Tables
1. Global Kidney Fibrosis Treatment Market: snapshot
2. Drivers of the Kidney Fibrosis Treatment Market: impact analysis
3. North America Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
4. North America Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
5. The U.S. Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
6. The U.S. Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
7. Rest of North America Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
8. Rest of North America Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
9. Europe Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
10. Europe Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
11. UK Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
12. UK Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
13. France Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
14. France Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
15. Germany Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
16. Germany Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
17. Rest of Europe Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
18. Rest of Europe Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
19. Asia Pacific Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
20. Asia Pacific Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
21. China Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
22. China Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
23. Japan Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
24. Japan Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
25. India Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
26. India Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
27. Rest of Asia Pacific Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
28. Rest of Asia Pacific Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
29. Latin America Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
30. Latin America Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
31. Brazil Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
32. Brazil Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
33. Rest of Latin America Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
34. Rest of Latin America Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
35. The Middle East and Africa Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
36. The Middle East and Africa Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
37. Saudi Arabia Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
38. Saudi Arabia Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
39. South Africa Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
40. South Africa Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
41. Rest of the Middle East & Africa Kidney Fibrosis Treatment Market revenue, By Therapeutics , 2015–2025 (USD Billion)
42. Rest of the Middle East & Africa Kidney Fibrosis Treatment Market revenue, By Location of Testing, 2015–2025 (USD Billion)
Methodology
FrequentlyAsked Questions
Escalating occurrence of chronic disorders due to unhealthy food habits has resulted in kidney fibrosis cases, thereby culminating into huge market demand in the upcoming years. Surge in the aging population along with massive awareness pertaining to renal fibrosis therapy will prompt the kidney fibrosis market expansion over the forthcoming years. Rise in the frequency of obesity with changing food patterns has resulted in increase in kidney problems, thereby driving the market earnings. Moreover, rise in health consciousness among the various age-groups of population will culminate into massive market penetration across the globe over the upcoming years.
global Kidney Fibrosis Treatment Market was valued at USD 4.78 Billion in 2023 and is projected to hit USD 7.65 Billion by 2032, with a compound annual growth rate (CAGR) of 4.8% during the forecast period 2024-2032.
North America is likely to make remarkable contributions towards overall market size during 2024-2032. The surge in the expansion of market in the sub-continent over the estimated timespan is due to surge in the population base suffering from kidney ailments. In addition to this, rise in the launching of end-stage kidney disorder therapy in the country such as the U.S. will provide lucrative growth avenues for kidney fibrosis treatment market in North America over the assessment period. Rise in the CRO activities and surge in the healthcare spending in the U.S. and Canada has further added to the expansion of the market in the region. As per CDC, nearly 37 million adult populations were slated to have been affected due to chronic kidney ailments during 2019. This accounted for 15% of total adult population in the U.S. Apart from this, CDC has reported that in the U.S. children above the age of 18 suffer from polycystic kidney disorder and glomerulonephritis. All these aforementioned factors will drive the demand for kidney fibrosis therapy in the U.S., thereby driving the regional market trends.
The key players profiled in the report include InterMune Inc., Merck & Co., Pfizer Inc., La Jolla Pharmaceutical Company, F. Hoffman-La Roche Ltd., Galectin Therapeutics, BioLine Rx Ltd., Genzyme Corporation, and ProMetic Life-Sciences Inc.
Choose License Type
List of Contents
Market InsightsIntroductionMarket, By TherapeuticMarket, By End-UserMarket, By GeographyReport ScopeMarket Growth DriversNorth America To Erupt As Global Market Leader During Forecast TimeframeThe global kidney fibrosis treatment market is segmented as follows:By therapeutics:By location of testing:By RegionRelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed